Literature DB >> 2843671

Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells.

S S Heinzel1, P J Krysan, M P Calos, R B DuBridge.   

Abstract

We have increased the copy number of Epstein-Barr virus vectors that also carry the origin of replication of simian virus 40 (SV40) by providing a transient dose of SV40 T antigen. T antigen was supplied in trans by transfection of a nonreplicating plasmid which expresses T antigen into cells carrying Epstein-Barr virus-SV40 vectors. A significant increase in vector copy number occurred over the next few days. We also observed a high frequency of intramolecular recombination when the vector carried a repeat segment in direct orientation, but not when the repeat was in inverted orientation or absent. Furthermore, by following the mutation frequency for a marker on the vector after induction of SV40 replication, it was determined that SV40 replication generates a detectable increase in the deletion frequency but no measurable increase in the frequency of point mutations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843671      PMCID: PMC253517          DOI: 10.1128/JVI.62.10.3738-3746.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Negative control of DNA replication in composite SV40-bovine papilloma virus plasmids.

Authors:  J M Roberts; H Weintraub
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

2.  A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.

Authors:  D Reisman; J Yates; B Sugden
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

3.  Chemically induced mutagenesis in a shuttle vector with a low-background mutant frequency.

Authors:  N R Drinkwater; D K Klinedinst
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

4.  Replication and supercoiling of simian virus 40 DNA in cell extracts from human cells.

Authors:  B W Stillman; Y Gluzman
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

5.  Repression of bovine papilloma virus replication is mediated by a virally encoded trans-acting factor.

Authors:  L Berg; M Lusky; A Stenlund; M R Botchan
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

6.  Electroporation for the efficient transfection of mammalian cells with DNA.

Authors:  G Chu; H Hayakawa; P Berg
Journal:  Nucleic Acids Res       Date:  1987-02-11       Impact factor: 16.971

7.  Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.

Authors:  R B DuBridge; P Tang; H C Hsia; P M Leong; J H Miller; M P Calos
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

8.  Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells.

Authors:  J L Yates; N Warren; B Sugden
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

9.  Alu-Alu recombination deletes splice acceptor sites and produces secreted low density lipoprotein receptor in a subject with familial hypercholesterolemia.

Authors:  M A Lehrman; D W Russell; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

10.  Amplification of a bovine papillomavirus-simian virus 40 chimera.

Authors:  R B DuBridge; M Lusky; M R Botchan; M P Calos
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more
  28 in total

1.  Conformational changes in tertiary structure near the ligand binding site of an integrin I domain.

Authors:  C Oxvig; C Lu; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

2.  Integrin CD11a cytoplasmic tail interacts with the CD45 membrane-proximal protein tyrosine phosphatase domain 1.

Authors:  Xin Geng; Ren-Hong Tang; S K Alex Law; Suet-Mien Tan
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

3.  Optimized expression vector for ion channel studies in Xenopus oocytes and mammalian cells using alfalfa mosaic virus.

Authors:  Srinivasan P Venkatachalan; Jeremy D Bushman; José L Mercado; Feyza Sancar; Kelly R Christopherson; Andrew J Boileau
Journal:  Pflugers Arch       Date:  2006-12-05       Impact factor: 3.657

4.  Structural plasticity in Ig superfamily domain 4 of ICAM-1 mediates cell surface dimerization.

Authors:  Xuehui Chen; Thomas Doohun Kim; Christopher V Carman; Li-Zhi Mi; Gang Song; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-19       Impact factor: 11.205

5.  Replication control of autonomously replicating human sequences.

Authors:  S B Haase; M P Calos
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

6.  Autonomous DNA replication in human cells is affected by the size and the source of the DNA.

Authors:  S S Heinzel; P J Krysan; C T Tran; M P Calos
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

7.  Production of high-titer helper-free retroviruses by transient transfection.

Authors:  W S Pear; G P Nolan; M L Scott; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells.

Authors:  A J Henderson; K L Calame
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

9.  Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPase.

Authors:  Lisa A Hazelwood; R Benjamin Free; David M Cabrera; Mette Skinbjerg; David R Sibley
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

10.  The role of phosphorylation in D1 dopamine receptor desensitization: evidence for a novel mechanism of arrestin association.

Authors:  Ok-Jin Kim; Benjamin R Gardner; Daniel B Williams; Paul S Marinec; David M Cabrera; Jennifer D Peters; Chun C Mak; Kyeong-Man Kim; David R Sibley
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.